• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT HBSAG REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT HBSAG REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 06C36-76
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, architect (b)(6), list 6c36, that has a similar product distributed in the us, list number 4p53.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Additional information section 1 patient information: patient 1 - (b)(6) year old male.Patient 2 - (b)(6) year old male.Patient 3 - (b)(6) year old male.Patient 4 - (b)(6) year old female.
 
Event Description
The customer obtained false negative architect (b)(6) results for four samples.The customer indicated the samples were positive for dna.The following results were provided: patient 1 - (b)(6) year old male with chronic (b)(6): 0 and 0.01 iu/ml on two architect analyzers and 0 iu/ml on alinity (b)(6).Patient 2 - (b)(6) year old male with liver fibrosis: 0.04 and 0.02 iu/ml on two architect analyzers; alinity (b)(6).Patient 3 - (b)(6) year old male with liver transplant: 0 and 0 iu/ml on two architect analyzers and 0 iu/ml on alinity (b)(6).Patient 4 - (b)(6) year old female with chronic (b)(6): 0.03 and 0.02 iu/ml on two architect analyzers and 0.02 iu/ml on the alinity (b)(6).No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation included a search for similar complaints, and review of complaint text, trending data, labeling, and device history records.In-house testing of reagent lot 14116fn00 was also completed.Return testing was not completed as returns were not available.Review of trending data did not identify any trends for the issue.Device history record review for reagent lot 14116fn00 did not identify any potential non-conformances, or deviations.Labeling was reviewed and found to adequately address the issue under review.In house testing of panels which mimic patient samples was completed using retained kits of the complaint lot.All specifications were met indicating that the lot is performing acceptably.Based on the investigation, no systemic issue or deficiency of the architect hbsag assay, lot number 14116fn00 was identified.
 
Event Description
The customer obtained false negative architect hbsag results for four samples.The customer indicated the samples were positive for dna.The following results were provided: patient 1 - 54 year old male with chronic hepatitis b: 0 and 0.01 iu/ml on two architect analyzers and 0 iu/ml on alinity hbsag.Hbeab and hbcab and dna positive.Patient 2 - 30 yea old male with liver fibrosis: 0.04 and 0.02 iu/ml on two architect analyzers; alinity hbsag 0.05 iu/ml positive, hbeag, hbcab and dna positive patient 3 - 54 year old male with liver transplant: 0 and 0 iu/ml on two architect analyzers and 0 iu/ml on alinity hbsag; positive results for hbsab, hbeab, hbcab and dna.Patient 4 - 32 year old female with chronic hepatitis b: 0.03 and 0.02 iu/ml on two architect analyzers and 0.02 iu/ml on the alinity hbsag; positive results for hbcab and dna.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HBSAG REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
MDR Report Key10823560
MDR Text Key249659836
Report Number3008344661-2020-00107
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/18/2021
Device Catalogue Number06C36-76
Device Lot Number14116FN00
Was Device Available for Evaluation? No
Date Manufacturer Received02/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2K PROC MOD, 03M74-01, (B)(6) ; ARC I2K PROC MOD, 03M74-01, (B)(6)
-
-